A Study to Assess Long-term Safety, Tolerability, and Efficacy of Rocatinlimab in Adult and Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD)
Clinical trial NCT05882877 · TERMINATED
Trial details
- NCT number
- NCT05882877
- Sponsor
- Amgen
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-31
- Primary completion
- 2026-07-01
- Enrollment
- 2621
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.